Advertisement
Advertisement
U.S. markets close in 45 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Becton, Dickinson and Company (BDX)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
266.98+3.29 (+1.25%)
As of 03:14PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close263.69
Open263.08
Bid266.82 x 800
Ask266.92 x 800
Day's Range262.61 - 267.50
52 Week Range229.40 - 277.29
Volume430,012
Avg. Volume979,212
Market Cap76.143B
Beta (5Y Monthly)0.61
PE Ratio (TTM)40.58
EPS (TTM)6.58
Earnings DateNov 02, 2022 - Nov 07, 2022
Forward Dividend & Yield3.48 (1.32%)
Ex-Dividend DateSep 08, 2022
1y Target Est274.55
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-25% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BDX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Becton, Dickinson and Company
    Analyst Report: Becton, Dickinson and CompanyBecton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
    Rating
    Fair Value
    Economic Moat
    11 days agoMorningstar
View more
Advertisement
Advertisement